OncoSec Medical Incorporated (NASDAQ:ONCS) Logo

The stock of Oncosec Medical Incorporated (NASDAQ:ONCS) registered a decrease of 19.67% in short interest. ONCS’s total short interest was 97,600 shares in December as published by FINRA. Its down 19.67% from 121,500 shares, reported previously. With 185,900 shares average volume, it will take short sellers 1 days to cover their ONCS’s short positions.

The stock decreased 7.92% or $0.16 during the last trading session, reaching $1.86. About 110,045 shares traded. OncoSec Medical Incorporated (NASDAQ:ONCS) has declined 74.26% since December 16, 2018 and is downtrending. It has underperformed by 74.26% the S&P500.

OncoSec Medical Incorporated, a biotechnology company, designs, develops, and commercializes gene therapies, therapeutics, and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer in the United States. The company has market cap of $20.00 million. The Company’s lead product candidate is the ImmunoPulse IL-12, which is in Phase II clinical trial for various indications, including metastatic melanoma and triple negative breast cancer. It currently has negative earnings. ImmunoPulse is an electroporation delivery device used in combination with the companyÂ’s therapeutic product candidates, including DNA plasmids that encode for immunologically active agents, and to deliver the therapeutic directly into the tumor and promote an inflammatory response against the cancer.

More notable recent OncoSec Medical Incorporated (NASDAQ:ONCS) news were published by: Seekingalpha.com which released: “YNDX, ONCS among premarket losers – Seeking Alpha” on October 11, 2019, also Nasdaq.com with their article: “BUZZ-U.S. STOCKS ON THE MOVE-Adobe, Oracle, Apple, Sarepta Therapeutics – Nasdaq” published on December 13, 2019, Streetinsider.com published: “Oncosec Medical (ONCS) to Present Interim Data from Ongoing KEYNOTE-890 Study of TAVO and KEYTRUDA in Late-Stage mTNBC at SABCS – StreetInsider.com” on December 05, 2019. More interesting news about OncoSec Medical Incorporated (NASDAQ:ONCS) were released by: Benzinga.com and their article: “58 Biggest Movers From Friday – Benzinga” published on December 16, 2019 as well as Seekingalpha.com‘s news article titled: “BBBY, ONCS among premarket gainers – Seeking Alpha” with publication date: October 10, 2019.

OncoSec Medical Incorporated (NASDAQ:ONCS) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



Source link